Acute reversal of allergen-induced airway hyperresponsiveness (AHR) by olodaterol is synergistically enhanced by tiotropium bromide

M. Smit, A. B. Zuidhof, I. S. T. Bos, H. Maarsingh, R. Gosens, J. Zaagsma, H. Meurs (Groningen, Netherlands)

Source: Annual Congress 2011 - Models of disease and drug actions
Session: Models of disease and drug actions
Session type: Poster Discussion
Number: 1784
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Smit, A. B. Zuidhof, I. S. T. Bos, H. Maarsingh, R. Gosens, J. Zaagsma, H. Meurs (Groningen, Netherlands). Acute reversal of allergen-induced airway hyperresponsiveness (AHR) by olodaterol is synergistically enhanced by tiotropium bromide. Eur Respir J 2011; 38: Suppl. 55, 1784

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Protection against allergen-induced airway hyperresponsiveness (AHR) by olodaterol in guinea pigs is synergistically enhanced by tiotropium
Source: Annual Congress 2012 - Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD
Year: 2012

Long-acting anticholinergic, aclidinium bromide (AB) significantly attenuates airway inflammation and hyper-responsiveness in an AF-induced murine model of asthma
Source: Annual Congress 2009 - Translational research/biomarkers
Year: 2009


Comparative study of the effects of tiotropium bromide and budesonide on allergen-induced airway remodeling
Source: Eur Respir J 2006; 28: Suppl. 50, 434s
Year: 2006

Influence of tiotropium bromide and formoterol on bronchial hyperresponsiveness in COPD
Source: Annual Congress 2012 - COPD treatment and varia
Year: 2012


Effects of salbutamol and enantiomers on allergen-induced asthmatic reactions and airway hyperreactivity
Source: Eur Respir J 2005; 25: 864-872
Year: 2005



Budesonide prevents but does not reverse sustained airway hyperresponsiveness in mice
Source: Eur Respir J 2008; 32: 970-978
Year: 2008



Dissociation in effects of fluticasone but not fluticasone/salmeterol on lung function and airway hyperresponsiveness in mild persistent asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 385s
Year: 2002

Inhibition of allergen-induced airway remodelling by tiotropium and budesonide: a comparison
Source: Eur Respir J 2007; 30: 653-661
Year: 2007



Dose reduction of inhaled corticosteroids under concomitant medication with montelukast in patients with asthma
Source: Eur Respir J 2002; 20: 1080-1087
Year: 2002



Montelukast versus fluticasone: effects on lung function, airway responsiveness and inflammation in moderate asthma
Source: Eur Respir J 2002; 20: 853-858
Year: 2002



Fluticasone furoate, a novel inhaled corticosteroid (ICS), provides sustained protection against amp airway hyperresponsiveness (AHR) in mild asthma
Source: Annual Congress 2009 - New drugs for airways disease
Year: 2009

Rapid protective effect of inhaled fluticasone on airway hyperresponsiveness to AMP in patients with fixed airway obstruction due to asthma but not COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 670s
Year: 2006

Effects of ciclesonide and fluticasone propionate on allergen-induced chronic airway inflammation and bronchial hyperreactivity in sensitized brown-Norway rats
Source: Eur Respir J 2003; 22: Suppl. 45, 280s
Year: 2003

Effect of budesonide/formoterol combination on an airway hyperresponsiveness and inflammation model in mice
Source: Eur Respir J 2004; 24: Suppl. 48, 131s
Year: 2004

Ipratropium bromide pre-treatment influences recovery after methacholine induced bronchospasm
Source: Eur Respir J 2002; 20: Suppl. 38, 505s
Year: 2002

Changes in objective markers following inhaled corticosteroids (ICS) in asthmatics with airway hyperresponsiveness (AHR) to mannitol
Source: International Congress 2019 – Airway physiology
Year: 2019

Allergen-induced airway decorin production is inhibited by budesonide and formoterol in a mouse model of asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 690s
Year: 2004

Effects of budesonide/formoterol maintenance therapy on airway hyperresponsiveness and inflammation in an allergic rat model
Source: Eur Respir J 2004; 24: Suppl. 48, 351s
Year: 2004

The inhaled PDE4 inhibitor UK-500,001 does not significantly inhibit airway responses to allergen and histamine
Source: Annual Congress 2007 - New drugs for asthma
Year: 2007


Effect of pinacidil, a KATPCO, on airway hyperresponsiveness and remodeling in guinea-pigs with asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 80s
Year: 2004